GemVax&KAEL Co.Ltd (082270) - Total Liabilities

Latest as of December 2025: ₩101.65 Billion KRW ≈ $68.88 Million USD

Based on the latest financial reports, GemVax&KAEL Co.Ltd (082270) has total liabilities worth ₩101.65 Billion KRW (≈ $68.88 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

GemVax&KAEL Co.Ltd - Total Liabilities Trend (2010–2025)

This chart illustrates how GemVax&KAEL Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See GemVax&KAEL Co.Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

GemVax&KAEL Co.Ltd Competitors by Total Liabilities

The table below lists competitors of GemVax&KAEL Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
GFPT Public Company Limited BK:GFPT	Thailand	฿6.17 Billion
Vetropack Holding SA SW:VETN	Switzerland	CHF479.00 Million
Dagang Nexchange Bhd KLSE:4456	Malaysia	RM1.75 Billion
Castro TA:CAST	Israel	ILA1.76 Billion
Beijing E-techstar Co Ltd SHE:300513	China	CN¥2.02 Billion
IVF Hartmann Holding AG SW:VBSN	Switzerland	CHF35.56 Million
Eupraxia Pharmaceuticals Inc TO:EPRX	Canada	CA$5.43 Million
Corem Property Group AB (publ) ST:CORE-B	Sweden	Skr38.77 Billion

Liability Composition Analysis (2010–2025)

This chart breaks down GemVax&KAEL Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GemVax&KAEL Co.Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.66	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.78	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.64	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GemVax&KAEL Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GemVax&KAEL Co.Ltd (2010–2025)

The table below shows the annual total liabilities of GemVax&KAEL Co.Ltd from 2010 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩101.65 Billion ≈ $68.88 Million	-16.51%
2024-12-31	₩121.74 Billion ≈ $82.50 Million	+348.65%
2023-12-31	₩27.13 Billion ≈ $18.39 Million	+61.60%
2022-12-31	₩16.79 Billion ≈ $11.38 Million	-8.50%
2021-12-31	₩18.35 Billion ≈ $12.44 Million	-22.22%
2020-12-31	₩23.59 Billion ≈ $15.99 Million	-65.42%
2019-12-31	₩68.23 Billion ≈ $46.24 Million	+16.07%
2018-12-31	₩58.78 Billion ≈ $39.84 Million	-37.27%
2017-12-31	₩93.71 Billion ≈ $63.51 Million	-31.22%
2016-12-31	₩136.25 Billion ≈ $92.34 Million	+2.81%
2015-12-31	₩132.53 Billion ≈ $89.81 Million	+112.55%
2014-12-31	₩62.35 Billion ≈ $42.26 Million	-20.50%
2013-12-31	₩78.43 Billion ≈ $53.15 Million	+9.38%
2012-12-31	₩71.70 Billion ≈ $48.59 Million	+24.38%
2011-12-31	₩57.65 Billion ≈ $39.07 Million	+226.40%
2010-12-31	₩17.66 Billion ≈ $11.97 Million	--

About GemVax&KAEL Co.Ltd

KQ:082270 Korea Semiconductors & Semiconductor Equipment

Market Cap

$336.03 Million

₩495.84 Billion KRW

Market Cap Rank

#14388 Global

#467 in Korea

Share Price

₩13900.00

Change (1 day)

-2.87%

52-Week Range

₩11870.00 - ₩68300.00

All Time High

₩69800.00